United States · FDA National Drug Code directory
IBTROZI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 84651-200_5154bda7-7ab4-4ad4-8fee-7fbe9ea692cc
- Product NDC
- 84651-200
- Form
- CAPSULE
- Composition / generic term
- taletrectinib
- Labeler
- Nuvation Bio Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20250611
- Source listing expiry
- 20271231
Source-listed ingredients
- TALETRECTINIB ADIPATE — 272 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (84651-200-90) / 90 CAPSULE in 1 BOTTLE · 84651-200-90
- 3 BOTTLE in 1 CARTON (84651-200-93) / 30 CAPSULE in 1 BOTTLE (84651-200-30) · 84651-200-93
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →